{"id":"https://openalex.org/W2145607335","doi":"https://doi.org/10.1158/1078-0432.ccr-07-1768","title":"Tumors Established with Cell Lines Selected for Oxaliplatin Resistance Respond to Oxaliplatin if Combined with Cetuximab","display_name":"Tumors Established with Cell Lines Selected for Oxaliplatin Resistance Respond to Oxaliplatin if Combined with Cetuximab","alternate_titles":[],"publication_year":2007,"publication_date":"2007-12-15","ids":{"openalex":"https://openalex.org/W2145607335","doi":"https://doi.org/10.1158/1078-0432.ccr-07-1768","mag":"2145607335","pmid":"https://pubmed.ncbi.nlm.nih.gov/18094427"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-07-1768","doi":"https://doi.org/10.1158/1078-0432.ccr-07-1768","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-07-1768","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2145607335"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088455715","display_name":"Marie C. Prewett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marie Prewett","raw_affiliation_strings":["1Department of Preclinical Pharmacology, ImClone Systems Incorporated, New York, New York and","Eli-Lilly"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Preclinical Pharmacology, ImClone Systems Incorporated, New York, New York and","institution_ids":[]},{"raw_affiliation_string":"Eli-Lilly","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083275726","display_name":"Dhanvanthri S. Deevi","orcid":"https://orcid.org/0009-0000-3862-057X","observed_orcids":["https://orcid.org/0009-0000-3862-057X"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dhanvanthri S. Deevi","raw_affiliation_strings":["1Department of Preclinical Pharmacology, ImClone Systems Incorporated, New York, New York and","Eli-Lilly"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Preclinical Pharmacology, ImClone Systems Incorporated, New York, New York and","institution_ids":[]},{"raw_affiliation_string":"Eli-Lilly","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104109628","display_name":"Rajiv Bassi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rajiv Bassi","raw_affiliation_strings":["1Department of Preclinical Pharmacology, ImClone Systems Incorporated, New York, New York and","Eli-Lilly"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Preclinical Pharmacology, ImClone Systems Incorporated, New York, New York and","institution_ids":[]},{"raw_affiliation_string":"Eli-Lilly","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Fan Fan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fan Fan","raw_affiliation_strings":["2Departments of Surgical Oncology and Cancer Biology, University of Texas, M. D. Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Departments of Surgical Oncology and Cancer Biology, University of Texas, M. D. Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042341684","display_name":"Lee M. Ellis","orcid":"https://orcid.org/0000-0001-8082-4904","observed_orcids":["https://orcid.org/0000-0001-8082-4904"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lee M. Ellis","raw_affiliation_strings":["2Departments of Surgical Oncology and Cancer Biology, University of Texas, M. D. Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Departments of Surgical Oncology and Cancer Biology, University of Texas, M. D. Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074599944","display_name":"Daniel J. Hicklin","orcid":"https://orcid.org/0009-0005-3474-9348","observed_orcids":["https://orcid.org/0009-0005-3474-9348"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Daniel J. Hicklin","raw_affiliation_strings":["1Department of Preclinical Pharmacology, ImClone Systems Incorporated, New York, New York and","Eli-Lilly"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Preclinical Pharmacology, ImClone Systems Incorporated, New York, New York and","institution_ids":[]},{"raw_affiliation_string":"Eli-Lilly","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075372173","display_name":"James R. Tonra","orcid":"https://orcid.org/0000-0003-3284-7516","observed_orcids":["https://orcid.org/0000-0003-3284-7516"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James R. Tonra","raw_affiliation_strings":["1Department of Preclinical Pharmacology, ImClone Systems Incorporated, New York, New York and","Eli-Lilly"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Preclinical Pharmacology, ImClone Systems Incorporated, New York, New York and","institution_ids":[]},{"raw_affiliation_string":"Eli-Lilly","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.968,"has_fulltext":false,"cited_by_count":58,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.85602511,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"13","issue":"24","first_page":"7432","last_page":"7440"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":0.005499999970197678,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9380000233650208},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.9390000104904175},{"id":"https://openalex.org/keywords/oxaliplatin-resistance","display_name":"oxaliplatin resistance","score":0.9369999766349792},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9860000014305115},{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.8730000257492065},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.7649999856948853},{"id":"https://openalex.org/keywords/nucleotide-excision-repair","display_name":"nucleotide excision repair","score":0.9750000238418579},{"id":"https://openalex.org/keywords/base-excision-repair","display_name":"base excision repair","score":0.8709999918937683},{"id":"https://openalex.org/keywords/platinum-dna-adducts","display_name":"platinum-DNA adducts","score":0.8339999914169312},{"id":"https://openalex.org/keywords/erk-signaling","display_name":"ERK signaling","score":0.7039999961853027},{"id":"https://openalex.org/keywords/akt-signaling","display_name":"Akt signaling","score":0.9919999837875366},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.652999997138977},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.746999979019165}],"concepts":[{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.9045509099960327},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.7844182252883911},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.613775372505188},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.4963257908821106},{"id":"https://openalex.org/C150777479","wikidata":"https://www.wikidata.org/wiki/Q176783","display_name":"AP site","level":4,"score":0.4182174503803253},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35202232003211975},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.3108976483345032},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30151867866516113},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29216673970222473},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16872382164001465},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.08744275569915771},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08421501517295837}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000076105","descriptor_name":"X-ray Repair Cross Complementing Protein 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077150","descriptor_name":"Oxaliplatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004260","descriptor_name":"DNA Repair","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004268","descriptor_name":"DNA-Binding Proteins","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018736","descriptor_name":"DNA Adducts","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048049","descriptor_name":"Extracellular Signal-Regulated MAP Kinases","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-07-1768","doi":"https://doi.org/10.1158/1078-0432.ccr-07-1768","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-07-1768","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:18094427","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18094427","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W1837926236","https://openalex.org/W1856551192","https://openalex.org/W1945415917","https://openalex.org/W1965734230","https://openalex.org/W1971577441","https://openalex.org/W1986523486","https://openalex.org/W1990495935","https://openalex.org/W2003680979","https://openalex.org/W2003726790","https://openalex.org/W2004718750","https://openalex.org/W2009714776","https://openalex.org/W2013889785","https://openalex.org/W2016882447","https://openalex.org/W2018520574","https://openalex.org/W2020359797","https://openalex.org/W2022594395","https://openalex.org/W2029935304","https://openalex.org/W2030477444","https://openalex.org/W2033192724","https://openalex.org/W2039633811","https://openalex.org/W2041005628","https://openalex.org/W2043497955","https://openalex.org/W2049903904","https://openalex.org/W2058645214","https://openalex.org/W2066113694","https://openalex.org/W2066881731","https://openalex.org/W2078500674","https://openalex.org/W2091604455","https://openalex.org/W2099082193","https://openalex.org/W2102897408","https://openalex.org/W2108081406","https://openalex.org/W2112727687","https://openalex.org/W2116298638","https://openalex.org/W2134259738","https://openalex.org/W2135376562","https://openalex.org/W2142564546","https://openalex.org/W2142807621","https://openalex.org/W2150256712","https://openalex.org/W2152116092","https://openalex.org/W2152387699","https://openalex.org/W2161339168","https://openalex.org/W2162957160","https://openalex.org/W2163650289","https://openalex.org/W2164277862","https://openalex.org/W2176781343","https://openalex.org/W2257938137"],"related_works":["https://openalex.org/W2004445514","https://openalex.org/W2105322609","https://openalex.org/W2898936873","https://openalex.org/W2280920407","https://openalex.org/W3017114811","https://openalex.org/W2055209074","https://openalex.org/W1630182881","https://openalex.org/W2020359797","https://openalex.org/W2097107257","https://openalex.org/W2073550136"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"establish":[2],"whether":[3],"cetuximab,":[4],"a":[5,179],"chimeric":[6],"IgG1":[7],"antibody":[8],"targeting":[9],"epidermal":[10],"growth":[11,82],"factor":[12],"receptor,":[13],"has":[14,27,239],"the":[15,137,160,167,182,189,225,240,244],"potential":[16,241],"to":[17,20,139,204,242],"restore":[18],"responsiveness":[19,138],"oxaliplatin":[21,66,140,235,247],"in":[22,32,49,53,56,83,116,123,166,248],"preclinical":[23],"cancer":[24,37,61,251],"models,":[25],"as":[26,68,70,87,89],"been":[28],"shown":[29],"with":[30,216],"irinotecan":[31,33],"refractory":[34],"metastatic":[35],"colorectal":[36,60,250],"patients.":[38],"EXPERIMENTAL":[39],"DESIGN:":[40],"The":[41],"effects":[42,205,217],"of":[43,78,91,102,107,113,132,136,147,159,169,177,181,191,195,227,246],"cetuximab":[44,121,144,174,196,223],"and":[45,55,99,111,134,153,210,229],"oxaliplatin,":[46],"alone":[47],"or":[48],"combination,":[50],"were":[51,76,202],"tested":[52],"vitro":[54],"vivo":[57],"using":[58],"human":[59],"cell":[62,73],"lines":[63],"selected":[64],"for":[65,188],"resistance,":[67],"well":[69,88],"parental":[71],"control":[72],"lines.":[74],"Evaluations":[75],"made":[77],"subcutaneous":[79,125],"xenograft":[80,126],"tumor":[81],"nu/nu":[84],"athymic":[85],"mice,":[86],"activation":[90],"mitogen-activated":[92,207],"protein":[93,200,208,221],"kinase":[94,97,209],"(extracellular":[95],"signal-regulated":[96],"1/2)":[98],"AKT,":[100],"expression":[101,146,176],"DNA":[103,109,198,219,233,255],"repair":[104,149,163,185,190,199,220,256],"genes,":[105],"density":[106],"apurinic/apyrimidinic":[108,192,230],"damage,":[110],"accumulation":[112,226],"platinum-DNA":[114,170],"adducts":[115],"vitro.":[117],"RESULTS:":[118],"Oxaliplatin":[119],"+":[120],"efficacy":[122],"murine":[124],"models":[127],"was":[128],"greater":[129],"than":[130],"that":[131],"monotherapies":[133],"independent":[135],"monotherapy.":[141],"In":[142,172,214],"vitro,":[143],"reduced":[145,175],"excision":[148,162,168,184],"cross-complementation":[150],"group":[151],"1":[152],"XPF,":[154],"which":[155],"are":[156],"key":[157],"components":[158],"nucleotide":[161],"pathway":[164,186,212],"involved":[165],"adducts.":[171],"addition,":[173],"XRCC1,":[178],"component":[180],"base":[183],"responsible":[187],"sites.":[193],"Effects":[194],"on":[197,206,218,232],"levels":[201],"downstream":[203],"AKT":[211],"activation.":[213],"line":[215],"expression,":[222],"increased":[224],"platinum":[228],"sites":[231],"during":[234],"treatment.":[236],"CONCLUSIONS:":[237],"Cetuximab":[238],"salvage":[243],"benefits":[245],"oxaliplatin-resistant":[249],"patients":[252],"by":[253],"reducing":[254],"capacity.":[257]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2145607335","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
